Odanacatib, a cathepsin‐K inhibitor for osteoporosis: a two‐year study in postmenopausal women with low bone density
HG Bone, MR McClung, C Roux… - Journal of Bone and …, 2010 - academic.oup.com
Cathepsin K, a cysteine protease expressed in osteoclasts, degrades type 1 collagen.
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density.
HG Bone, MR McClung, C Roux… - Journal of Bone and …, 2010 - europepmc.org
Cathepsin K, a cysteine protease expressed in osteoclasts, degrades type 1 collagen.
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density
HG Bone, MR McClung, C Roux… - Journal of bone …, 2010 - pubmed.ncbi.nlm.nih.gov
Cathepsin K, a cysteine protease expressed in osteoclasts, degrades type 1 collagen.
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib, a cathepsin‐K inhibitor for osteoporosis: A two‐year study in postmenopausal women with low bone density
HG Bone, MR McClung, C Roux… - Journal of Bone and …, 2010 - Wiley Online Library
Cathepsin K, a cysteine protease expressed in osteoclasts, degrades type 1 collagen.
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density.
HG Bone, MR McClung, C Roux… - Journal of Bone & …, 2010 - search.ebscohost.com
The article discusses a study which examined the role of the cathepsin K inhibitor
odanacatib in osteoporosis. The clinical trial involved postmenopausal women with low …
odanacatib in osteoporosis. The clinical trial involved postmenopausal women with low …
Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density
HG Bone, MR McClung, C Roux… - Journal of Bone …, 2010 - cris.maastrichtuniversity.nl
Cathepsin K, a cysteine protease expressed in osteoclasts, degrades type 1 collagen.
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
[PDF][PDF] Odanacatib, a cathepsin‐K inhibitor for osteoporosis: A two‐year study in postmenopausal women with low bone density
HG Bone, MR McClung, C Roux… - Journal of Bone and …, 2010 - Wiley Online Library
Cathepsin K, a cysteine protease expressed in osteoclasts, degrades type 1 collagen.
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density
HG Bone, MR McClung, C Roux… - Journal of Bone …, 2010 - researchworks.creighton.edu
Cathepsin K, a cysteine protease expressed in osteoclasts, degrades type 1 collagen.
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib selectively and reversibly inhibited cathepsin K and rapidly decreased bone …
Odanacatib, a cathepsin‐K inhibitor for osteoporosis: A two‐year study in postmenopausal women with low bone density
HG Bone, MR McClung, C Roux, RR Recker… - Journal of Bone and …, 2010 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Cathepsin K, a cysteine protease expressed in
osteoclasts, degrades type 1 collagen. Odanacatib selectively and reversibly inhibited …
osteoclasts, degrades type 1 collagen. Odanacatib selectively and reversibly inhibited …
[引用][C] Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density
HG BONE, MR MCCLUNG, C ROUX… - Journal of bone and …, 2010 - pascal-francis.inist.fr
Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in
Postmenopausal Women With Low Bone Density CNRS Inist Pascal-Francis CNRS Pascal …
Postmenopausal Women With Low Bone Density CNRS Inist Pascal-Francis CNRS Pascal …